The immunopotentiator effects of nefopam.

Int Immunopharmacol

Department of Parmacology, Faculty of Medicine, Assiut University, Assiut, Egypt.

Published: February 2007

The effects of opiate analgesics and non-steroidal anti-inflammatory drugs on the immune functions have been reported. The effect of the non-opiate analgesic nefopam on the immune functions has not yet been investigated. Male Swiss albino mice were treated with either heat killed E. coli or saline. They were classified into 12 groups. The effects of subacute (15 mg/kg/12 h S.C. daily for one week) and chronic (10 mg/kg/12 h S.C. daily for one month) treatment with nefopam on the levels of interferon-gamma (IFN-gamma) and total immunoglobulins were examined in both normal and immunized mice. Also, the effect of the chronic administration of nefopam on the phagocytic activity of peritoneal macrophage was evaluated in both normal and immunized mice. Subacute and chronic administration of nefopam induced no significant raise in the level of interferon-gamma (IFN-gamma) or in the level of total immunoglobulins in non-immunized animals, while subacute and chronic treatment with nefopam augmented markedly the immunization induced increase of level of interferon-gamma (IFN-gamma). Furthermore, chronic treatment with nefopam potentiated significantly the production of total immunoglobulin induced by heat killed E. coli. Chronic treatment with nefopam also was associated with significant enhancement of innate immune response reflected in the pronounced increase in the phagocytic activity of macrophages in non-immunized and immunized animals. The enhancement of phagocytic activity of macrophages by nefopam in immunized animals was significantly higher than that of non-immunized animals. These findings revealed that nefopam has the ability to trigger the immune response for bacterial antigen. The mechanism behind the immunostimulatory effect of nefopam requires further investigation, but it may be due, at least in part, to the inhibitory effect of nefopam on the serotonin and norepinephrine reuptake at nerve endings. In conclusion, our findings postulated that nefopam stimulated the immune functions and improved the defence mechanism. This information may be of future therapeutic value in diseases that need immunologic enhancement.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2006.10.010DOI Listing

Publication Analysis

Top Keywords

treatment nefopam
16
nefopam
13
immune functions
12
interferon-gamma ifn-gamma
12
phagocytic activity
12
chronic treatment
12
heat killed
8
killed coli
8
mg/kg/12 daily
8
total immunoglobulins
8

Similar Publications

Article Synopsis
  • The study focused on managing acute pain in adults with sickle cell disease (SCD), particularly during vaso-occlusive crises (VOC), which occur when sickle cells block microvessels, leading to severe pain.* -
  • An analysis of 118 cases revealed that most patients (86.61%) had the SS sickle cell phenotype, with predominant pain in the lower limbs and spine, and a majority experiencing intense to unbearable pain.* -
  • The findings underscore the effectiveness of multimodal analgesia as a treatment approach, while also indicating significant variability in pain management practices, suggesting a need for tailored recommendations.*
View Article and Find Full Text PDF

Pharmacological pain treatment in older persons is presented by a multi-disciplinary group of European pain experts. Drugs recommended for acute or chronic nociceptive pain, also for neuropathic pain and the routes of administration of choice are the same as those prescribed for younger persons but comorbidities and polypharmacy in older persons increase the risk of adverse effects and drug interactions. Not all drugs are available or authorised in all European countries.

View Article and Find Full Text PDF

Opioid free versus opioid sparing strategies for multimodal antinociception during laparoscopic colectomy: a randomised controlled trial.

Anaesth Crit Care Pain Med

December 2024

Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine, University of California Los Angeles, California, United States. Electronic address:

Article Synopsis
  • The study aimed to determine if opioid-free anesthesia (OFA) could reduce postoperative opioid use during laparoscopic colectomy compared to opioid-sparing anesthesia (OSA).
  • In a clinical trial with 160 patients, those receiving OFA did not show significantly lower opioid consumption 48 hours post-surgery compared to those on OSA.
  • Both anesthesia methods resulted in similar pain control and adverse events, although the OFA group experienced increased bradycardia incidents.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!